This statistic shows the cost to bring a biopharmaceutical asset to market among mid-to-large cap biopharma companies from 2013 to 2020. According to the data, the cost to bring an asset to market was highest in 2018, with some 2.8 billion U.S. dollars.
Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies from 2013 to 2020
(in billion U.S. dollars)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Statista Accounts:
Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.
Deloitte. (May 24, 2021). Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies from 2013 to 2020 (in billion U.S. dollars) [Graph]. In Statista. Retrieved May 18, 2022, from https://www.statista.com/statistics/825721/cost-to-bring-biopharmaceutical-assets-to-market-for-mid-cap-companies/
Deloitte. "Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies from 2013 to 2020 (in billion U.S. dollars)." Chart. May 24, 2021. Statista. Accessed May 18, 2022. https://www.statista.com/statistics/825721/cost-to-bring-biopharmaceutical-assets-to-market-for-mid-cap-companies/
Deloitte. (2021). Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies from 2013 to 2020 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: May 18, 2022. https://www.statista.com/statistics/825721/cost-to-bring-biopharmaceutical-assets-to-market-for-mid-cap-companies/
Deloitte. "Average Cost to Bring a Pharmaceutical Asset to Market among mid Cap Biopharma Companies from 2013 to 2020 (in Billion U.S. Dollars)." Statista, Statista Inc., 24 May 2021, https://www.statista.com/statistics/825721/cost-to-bring-biopharmaceutical-assets-to-market-for-mid-cap-companies/
Deloitte, Average cost to bring a pharmaceutical asset to market among mid cap biopharma companies from 2013 to 2020 (in billion U.S. dollars) Statista, https://www.statista.com/statistics/825721/cost-to-bring-biopharmaceutical-assets-to-market-for-mid-cap-companies/ (last visited May 18, 2022)
